Effects of chronic administration of L-arginine on vasoactive responses induced by endothelin-1 and its plasma level in streptozotocin-induced diabetic rats

Journal of Smooth Muscle Research

Volumn 38, Issue 4-5, 2002, Pages 101-115

  Makino, Ayako ^a   Kamata, Katsuo ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

Diabetes; Endothelin 1; L arginine; Mesenteric artery; Nitric oxide; Rat

Indexed keywords

ACETYLCHOLINE; ARGININE; ENDOTHELIN 1; METHOXAMINE; NITRIC OXIDE; STREPTOZOCIN; VASOACTIVE AGENT; VASODILATOR AGENT;

AMINO ACID ANALYSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; LONG TERM EXPOSURE; MESENTERY BLOOD FLOW; NONHUMAN; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RAT; REGULATORY MECHANISM; STATISTICAL SIGNIFICANCE; STREPTOZOCIN DIABETES; SYMPTOMATOLOGY; VASOCONSTRICTION; VASODILATATION;

ANIMALS; ARGININE; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ENDOTHELIN-1; MALE; MESENTERIC ARTERIES; METHOXAMINE; OSMOLAR CONCENTRATION; RATS; RATS, WISTAR; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 0036825404     PISSN: 09168737     EISSN: None     Source Type: Journal    
DOI: 10.1540/jsmr.38.101     Document Type: Article

References (56)

1. Adkins, W.K. and Taylor, A.E. (1990). Role of xanthine oxidase and neutrophils in ischemia-reperfusion injury in rabbit lung. J. Appl. Physiol. 69: 2012-2018.
2. Bayraktutan, U., Draper, N., Lang, D. and Shah, A.M. (1998). Expression of functional neutrophil-type NADPH oxidase in cultured rat coronary microvascular endothelial cells. Cardiovasc. Res. 38: 256-262.
3. Boulanger, C. and Lucher, T.F. (1990). Release of endothelin from the porcine aorta: inhibition by endothelium-derived nitric oxide. J. Clin. Invest. 85: 587-590.
4. Bysani, G.K. Kennedy, T.P., Ky, N, Rao, N.V., Blaze, C.A. and Hoidal, J.R. (1990). Role of cytochrome P-450 in reperfusion injury of the rabbit lung. J. Clin. Invest. 86: 1434-1441.
5. Calver, A., Collier, J. and Vallance, P. (1992). Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J. Clin. Invest. 90: 2548-2554.
6. Cohen, R.A. (1993). Dysfunction of vascular endothelium in diabetes mellitus. Circulation 87 (suppl V): V67-V76.
7. Collier, A., Leach, J.P., Mclellan, A., Jardine, A., Morton, J.J. and Small, M. (1992). Plasma endothelin-like immunoreactivity levels in IDDM patients with microalbuminuria. Diabetes Care. 15: 1038-1040.
8. Cosentino, F., Hishikawa, K., Katusic, Z.S. and Lucher, T.F. (1997). High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 96: 25-28.
9. Cosentino, F. and Katusic, Z.S. (1994). Does endothelin-1 play a role in the pathogenesis of cerebral vasospasm? Stroke 25: 904-908.
10. Diederich, D., Skopec, J., Diederich, A. and Dai, F.X. (1994). Endothelial dysfunction in mesenteric resistance arteries of diabetic rats: role of free radicals. Am. J. Physiol. 266: H1153-H1161.
11. Dubowski, K.M. (1962). An O-toluidine method for body-fluid glucose determination. Clin. Chem. 8: 215-235.
12. Elliott, T.G., Cockcroft, J.R., Groop, P.H., Viberti, G.C. and Ritter, J.M. (1993). Inhibition of nitric oxide synthesis in forearm vasculature of insulin-dependent diabetic patients: blunted vasoconstriction in patients with microalbumiuria. Clin. Sci. 85: 687-693.
13. Filep, J.P. (1997). Endogenous endothelin modulates blood pressure, plasma volume, and albumin escape after systemic nitric oxide blockade. Hypertension 30: 22-28.
14. Gorlach, A., Brandes, R.P., Nguyen, K., Amidi, M., Dehghani, F. and Busse, R. (2000). A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ. Res. 87: 26-32.
15. Hasdai, D., Holmes, D.R. Jr., Garratt, K.N., Edwards, W.D. and Lerman, A. (1997). Mechanical pressure and stretch release endothelin-1 from human atherosclerotic coronary arteries in vivo. Circulation 95: 357-362.
16. Hattori, Y., Kawasaki, H., Abe, K. and Kanno, M. (1991). Superoxide dismutase recovers altered endothelium-dependent relaxation in diabetic rat aorta. Am. J. Physiol. 261: H1086-H1094.
17. Haynes, W.G. and Webb, D.J. (1994). Contribution of endogenous generation of endothelin-1 to basal vascular tone. Lancet 344: 852-854.
18. Huvers, F.C., De Leeuw, P.W., Houben, A.J.H.M., De Haan, C.H.A., Hamulyak, K., Schouten, H., Wolffenbuttel, B.H.R. and Schaper, N.C. (1999). Endothelium-dependent vasodilatation, plasma markers of endothelial function, and adrenergic vasoconstrictor response in type 1 diabetes under near-normoglycemic conditions. Diabetes 48: 1300-1307.
19. Jones, S.A., O'donnell, V.B., Wood, J.D., Broughton, J.P., Hughes, E.J. and Jones, O.T. (1996). Expression of phagocyte NADPH oxidase components in human endothelial cells. Am. J. Physiol. 271: H1626-H1634.
20. Kanie, N. and Kamata, K. (2002). Effects of chronic administration of the novel endothelin antagonist J-104132 on endothelial dysfunction in streptozotocin-induced diabetic rat. Br. J. Pharmacol. 135: 1935-1942.
21. Kamata, K. and Kobayashi, T. (1996). Changes in superoxide dismutase mRNA expression by streptozotocin-induced diabetes. Br. J. Pharmacol. 119: 583-589.
22. Kamata, K., Umeda, F. and Kasuya, Y. (1996). Possible existence of novel endothelium-derived relaxing factor in the endothelium of rat mesenteric arterial bed. J. Cardiovasc. Pharmacol. 27: 601-606.
23. 1-adrenoceptor agonist. Br. J Pharmacol. 120: 1221-1226.
24. Kobayashi, T. and Kamata, K. (1999). Relationship among cholesterol, superoxide anion and endothelium-dependent relaxation in diabetic rats. Eur. J. Pharmacol. 365: 213-222.
25. Kobayashi, T. and Kamata, K. (2001). Effect of chronic insulin treatment on NO production and endothelium-dependent relaxation in aortae from established STZ-induced diabetic rats. Atheroscrelosis 155: 313-321.
26. Lal, H., Woodwar, B. and Williams, K.I. (1996). Investigation of the contribution of nitric oxide and prostaglandins to the actions of endothelins and sarafotoxin 6c in rat isolated perfused lungs. Br. J. Pharmacol. 118: 1931-1937.
27. Lerman, A., Holmes, D.R. Jr., Bell, M.R., Garratt, K.N. and Burnett, J.C. Jr. (1995). Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans. Circulation 92: 2426-2431.
28. Lucher, T.F., Boulanger, C.M., Yang, Z., Noll, G. and Dohi, Y. (1993). Interactions between endothelium-derived relaxing and contracting factors in health and cardiovascular disease. Circulation 87 (suppl V): V36-V44.
29. Magazine, H.I., Srivastava, K.D. (1996). Thrombin-induced vascular reactivity is modulated by ETB receptor-coupled nitric oxide release in rat aorta. Am. J. Physiol. 271: C923-C930.
30. Makimattila, S., Mantysaari, M., Groop, O.H., Summanen, P., Virkamaki, A., Schlenzka, A., Fagerudd, J. and Yki Jarvinen, H. (1997). Hyperactivity to nitrovasodilators in forearm vasculature is related to autonomic dysfunction in insulin-dependent diabetic mellitus. Circulation 95: 618-625.
31. Makino, A. and Kamata, K. (1998a). Elevated plasma endothelin-1 level in streptozotocin-induced diabetic rats and responsiveness of the mesenteric arterial beds to endothelin-1. Br. J. Pharmacol. 123: 1065-1072.
32. 2 of vasoconstriction induced by an α-agonist in mesenteric arterial bed from diabetic rats. Diabetologia 41: 1410-1418.
33. Makino, A. and Kamata, K. (2000). Time-course changes in plasma endothelin-1 and its effects on the mesenteric arterial bed in streptozotocin-induced diabetic rats. Diabetes Obes. Metab. 2: 47-55.
34. Makino, A., Oda, S. and Kamata, K. (2001). Mechanisms underlying increased release of endothelin-1 from aorta in diabetic rats. Peptides 22: 639-645.
35. Millard, S.L., Russell, J.A., Morin III, F.C., Adolf, M.A., Gugino, S.F. and Steinhorn, R.H. (1998). cGMP inhibition of endothelin-stimulated inositol phosphate production in the fetal lamp pulmonary artery. Pulm. Pharmacol. Ther. 11: 201-204.
36. Miyauchi, T. and Goto, K. (1999). Heart failure and endothelin receptor antagonists. Trend. Pharmacol. Sci. 20: 210-217.
37. Moncada, S., Palmer, R.M. J. and Higgs, E.A. (1991). Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43: 109-142.
38. Palmer, R.M.J., Ashton, D.S. and Moncada, S. (1988). Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333: 664-666.
39. Patterson, C., Ruef, J., Madamanchi, N.R., Barry-Lane, P., Hu, Z., Horaist, C., Ballinger, C.A., Brasier, A.R., Bode, C. and Runge, M.S. (1999). Stimulation of a vascular smooth muscle cell NAD (P) H oxidase by thrombin. Evidence that p47(phox) may participate in forming this oxidase in vitro and in vivo. J. Biol. Chem. 274: 19814-19822.
40. Pieper, G.M., Jordan, M., Adams, M.B. and Roza, A.M. (1995). Syngenetic pancreatic islet transplantation reverses endothelial dysfunction in experimental diabetes. Diabetes 44: 1106-1113.
41. Pieper, G.M. and Peltier, B.A. (1995). Amelioration by L-arginine of a dysfunctional arginine/nitric oxide pathway in diabetic endothelium. J. Cardiovasc. Pharmacol. 25: 397-403.
42. Pieper, G.M., Siebeneich, W. and Dondlinger, L.A. (1996). Short-term oral administration of L-arginine reverses defective endothelium-dependent relaxation and cGMP generation in diabetes. Eur. J. Pharmacol. 317: 317-320.
43. Poston, L. and Taylor, P.D. (1995). Endothelium-mediated vascular function in insulin-dependent diabetes mellitus. Clin. Sci. 88: 245-255.
44. Rabelink, T.J., Kaasjager, K.A., Stroes, E.S. and Koomans, H.A. (1996). Endothelin in renal pathophysiology: from experimental to therapeutic application. Kidney Int. 50: 1827-1833.
45. Richard, V., Hogie, M., Clozel, M., Loffler, B. and Thuillez, C. (1995). In vivo evidence of an endothelin-induced vasopressor tone after inhibition of nitric oxide synthesis in rats. Circulation 91: 771-775.
46. Rosen, P., Ballhausen, T., Bloch, W. and Addicks, K. (1995). Endothelial relaxation is disturbed by oxidative stress in the diabetic rat: influence of tocopherol as antioxidant. Diabetologia 38: 1157-1168.
47. Roux, S., Breu, V., Ertel, S.I. and Clozel, M. (1999). Endothelin antagonism with bosentan: a review of potential applications. J. Mol. Med. 77: 364-376.
48. Saenz de Tejada, I., Goldstein, I., Azadzoi, K., Krane, R.J. and Cohen, R.A. (1989). Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N. England. J. Med. 320: 1025-1030.
49. Sakuma, I., Asajima, H., Fukao, M., Tohse, N., Tamura, M. and Kitabatake, A. (1993). Possible contribution of potassium channels to the endothelin-induced dilatation of rat coronary vascular beds. J. Cardiovasc. Pharmacol. 22: S232-S238.
50. Smits, P., Kapma, J.A., Jacobs, M.C., Jutterman, J. and Thien, T. (1993). Endothelium-dependent vascular relaxation in patients with type I diabetes. Diabetes 42: 148-153.
51. Sugimoto, H., Shikata, K., Matsuda, M., Kushiro, M., Hayashi, Y., Hiragushi, K., Wada, J. and Makino, H. (1998). Increased expression of endothelial cell nitric oxide synthase (ecNOS) in afferent and glomerular endothelial cells is involved in glomerular hyperfiltration of diabetic nephropathy. Diabetologia 41: 1426-1434.
52. Takahashi, K., Ghatei, M.A., Lam, H.C., O'halloran, D.J. and Bloom, S.R. (1990). Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia 33: 306-310.
53. Tsunoda, K., Abe, K., Sato, T., Yokosawa, S. and Yoshinaga, K. (1991). Decreased conversion of big endothelin-1 to endothelin-1 in patients with diabetes mellitus. Clin. Exp. Pharmacol. Physiol. 18: 731-732.
54. Ushio-Fukai, M., Zafari, A.M., Fukui, T., Ishizaka, N. and Griendling, K.K. (1996). p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J. Biol. Chem. 271: 23317-23321.
55. Yamada, K. and Nabeshima, T. (1997). Simultaneous measurement of nitrite and nitrate levels as indices of nitric oxide release in the cerebellum of conscious rats. J. Neurochem. 68;1234-1243.
56. Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, M., Mitsui, Y., Yazaki,Y., Goto, K. and Masaki, T. (1989). A novel potent vasoconstrictor peptideproduced by vascular endothelial cells. Nature 332: 411-415.